By intravenous infusion, Tanshinone IIA can maintain stable plasma concentrations, improve blood circulation, dilate coronary arteries, and lower heart rate, thereby improving angina-related indices and hemorheological parameters, optimizing blood lipid profiles, and reducing C-reactive protein (CRP) levels. Here, CRP is linked to angina pectoris.